Demant A/S Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 2/7/2026)
| Balance Sheet | Total Assets | 40,025,000,000.00 | ROE | 25.19 % |
| Balance Sheet | Total Equity | 11,241,000,000.00 | ROA | 3.95 % |
| Cashflow | Capital Expenditures | -652,000,000.00 | P/FCF | 22.66 |
| Cashflow | Free Cash Flow | 3,302,000,128.00 | – | – |
| Cashflow | Operating Cash Flow | 3,954,000,000.00 | P/CF | 18.92 |
| Income | Earnings per Share (diluted) | 7.33 | Div. Yield | – |
| Income | Net Income | 1,545,000,000.00 | P/E | 48.40 |
| Income | Shares Outstanding | 208,857,200.00 | P/B | 7.60 |
| Income | Total Revenue | 22,971,000,000.00 | P/S | 3.26 |
Ratios calculated on: 10/14/2026
Company Description
Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. It operates through two segments, Hearing Healthcare and Communications. The Hearing Healthcare segment offers hearing implants and aids, hearing care, and diagnostic products. The Communications segment offers headsets and solutions for the professional call center, office, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.demant.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more